您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
PI3 Kinase p110β Recombinant Rabbit mAb (S-1193-115)

PI3 Kinase p110β Recombinant Rabbit mAb (S-1193-115)

货号: S0B1024
价格: 600
规格: 25μl
介绍: -
其他: -
产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    PI3 Kinase p110 β
  • 分子别名

    PI3-kinase subunit beta; PI3K-beta; PI3Kbeta; PtdIns-3-kinase subunit beta; PIK3CB; PIK3C1
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cytoplasm, Nucleus
  • Accession

    P42338
  • 克隆号

    S-1193-115
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 应用

    ICC, WB
  • 反应种属 ?

    Hu, Ms, Rt
  • 阳性样本

    K562, MCF7, HeLa, C2C12, mouse brain, C6, rat brain
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

稀释度
应用 稀释度 推荐种属
WB 1:1000 Hu, Ms, Rt
ICC 1:50 Hu, Ms
背景介绍
  • PI3 Kinase p110β, also known as PIK3CB, is a catalytic subunit of the phosphoinositide 3-kinase (PI3K) family, which plays a crucial role in cellular processes such as growth, metabolism, and tumorigenesis. This isoform, along with p110α, generates lipid second messengers that initiate multiple signal transduction cascades upon receptor activation. In the context of non-small cell lung cancer (NSCLC), p110β overexpression is associated with clinical significance and specific mechanisms. High expression rates of p110β in NSCLC have been reported to be around 41.8%. Its overexpression is particularly linked to the loss of PTEN, a negative regulator of the PI3K pathway, and is negatively correlated with EGFR mutations. This suggests that p110β may play a role in tumors where PTEN is deficient, potentially driving tumor survival and progression. Moreover, studies have shown that p110β has kinase-independent functions in regulating cell proliferation and trafficking.

  • 免疫印迹

    • WB result of PI3 Kinase p110β Recombinant Rabbit mAb
      Primary antibody: PI3 Kinase p110 β Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: K562 whole cell lysate 20 µg
      Lane 2: MCF7 whole cell lysate 20 µg
      Lane 3: HeLa whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 123 kDa
      Observed MW: 120 kDa

    • WB result of PI3 Kinase p110β Recombinant Rabbit mAb
      Primary antibody: PI3 Kinase p110 β Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: C2C12 whole cell lysate 20 µg
      Lane 2: mouse brain lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 123 kDa
      Observed MW: 120 kDa

    • WB result of PI3 Kinase p110β Recombinant Rabbit mAb
      Primary antibody: PI3 Kinase p110 β Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: C6 whole cell lysate 20 µg
      Lane 2: rat brain lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 123 kDa
      Observed MW: 120 kDa

  • 免疫细胞化学

    • ICC shows positive staining in HeLa cells. Anti- PI3 Kinase p110β antibody was used at 1/50 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

    • ICC shows positive staining in C2C12 cells. Anti- PI3 Kinase p110β antibody was used at 1/50 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).